TLR2 and infection: A study conducted in children hospitalised for community-acquired pneumonia showed that treatment with pidotimod in combination with antibiotic therapy, compared to antibiotic therapy alone, reduced the potential risk of recurring infection, thanks to up-regulation of TLR-2 and increased production of IL-12 and TNF-α with a prolonged effect over time [14].